Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
-345K
-
Total reported value, excl. options
-
$74.6M
-
Value change
-
-$6.82M
-
Put/Call ratio
-
0.04
-
Number of buys
-
36
-
Number of sells
-
-30
-
Price
-
$4.65
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q3 2023
81 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q3 2023.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 55M outstanding shares and own 29.19% of the company stock.
Largest 10 shareholders include Blue Water Life Science Advisors, LP (4.7M shares), Polar Capital Holdings Plc (1.58M shares), BlackRock Inc. (1.45M shares), VANGUARD GROUP INC (1.35M shares), Kent Lake Capital LLC (747K shares), Board of Trustees of The Leland Stanford Junior University (620K shares), Uniplan Investment Counsel, Inc. (555K shares), MILLENNIUM MANAGEMENT LLC (543K shares), Parkman Healthcare Partners LLC (526K shares), and SVB WEALTH LLC (515K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.